These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 12768511

  • 21. [The clinical relevance of memantine use].
    Sobów T.
    Psychiatr Pol; 2004; 38(2):321-30. PubMed ID: 15307296
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
    Grossberg GT, Edwards KR, Zhao Q.
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
    [Abstract] [Full Text] [Related]

  • 24. [Memantine can relieve certain symptoms in Parkinson disease. Improvement achieved in two out of three described cases with dyskinesia and cognitive failure].
    Lökk J.
    Lakartidningen; 2004 Jun 03; 101(23):2003-6. PubMed ID: 15232837
    [Abstract] [Full Text] [Related]

  • 25. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.
    Lipton SA.
    Curr Alzheimer Res; 2005 Apr 03; 2(2):155-65. PubMed ID: 15974913
    [Abstract] [Full Text] [Related]

  • 26. Memantine: targeting glutamate excitotoxicity in Alzheimer's disease and other dementias.
    Molinuevo JL, Lladó A, Rami L.
    Am J Alzheimers Dis Other Demen; 2005 Apr 03; 20(2):77-85. PubMed ID: 15844753
    [Abstract] [Full Text] [Related]

  • 27. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS, Lipton SA.
    J Neurochem; 2006 Jun 03; 97(6):1611-26. PubMed ID: 16805772
    [Abstract] [Full Text] [Related]

  • 28. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X, Marszalec W, Toth PT, Huang J, Yeh JZ, Narahashi T.
    Neuropharmacology; 2006 Dec 03; 51(7-8):1181-91. PubMed ID: 17011596
    [Abstract] [Full Text] [Related]

  • 29. [Treatment of degenerative dementia disorders--who should be treated?].
    Hasselbalch SG, Kampmann JP.
    Ugeskr Laeger; 2009 Mar 02; 171(10):802-5. PubMed ID: 19265606
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Magnesium supplementation in the treatment of dementia patients.
    Ozturk S, Cillier AE.
    Med Hypotheses; 2006 Mar 02; 67(5):1223-5. PubMed ID: 16790324
    [Abstract] [Full Text] [Related]

  • 32. Memantine in dementia: a review of the current evidence.
    Herrmann N, Li A, Lanctôt K.
    Expert Opin Pharmacother; 2011 Apr 02; 12(5):787-800. PubMed ID: 21385152
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Drugs for treatment of Alzheimer's disease.
    Wilkinson D.
    Int J Clin Pract; 2001 Mar 02; 55(2):129-34. PubMed ID: 11321852
    [Abstract] [Full Text] [Related]

  • 35. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
    Lipton SA.
    Curr Drug Targets; 2007 May 02; 8(5):621-32. PubMed ID: 17504105
    [Abstract] [Full Text] [Related]

  • 36. Treatment options in Alzheimer's disease: maximizing benefit, managing expectations.
    Farlow MR, Miller ML, Pejovic V.
    Dement Geriatr Cogn Disord; 2008 May 02; 25(5):408-22. PubMed ID: 18391487
    [Abstract] [Full Text] [Related]

  • 37. Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain.
    Enz A, Gentsch C.
    Neuropharmacology; 2004 Sep 02; 47(3):408-13. PubMed ID: 15275830
    [Abstract] [Full Text] [Related]

  • 38. [New therapeutic options in Alzheimer's disease].
    García-Ruiz Espiga PJ, Echeverría A, García-Torres A, Contreras A.
    Rev Neurol; 2004 Sep 02; 42(8):478-81. PubMed ID: 16625510
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Memantine. Merz.
    Kilpatrick GJ, Tilbrook GS.
    Curr Opin Investig Drugs; 2002 May 02; 3(5):798-806. PubMed ID: 12090556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.